This text of Indiana § 16-34-2-4.7 ("Abortion complication"; required report; information for report;
quarterly public report) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
7.
(a)As used in this section, "abortion
complication" means only the following physical or psychological
conditions arising from the induction or performance of an abortion:
(4)Vaginal bleeding that qualifies as a Grade 2 or higher adverse
event according to the Common Terminology Criteria for Adverse
Events (CTCAE).
(7)Failure to terminate the pregnancy.
(8)Incomplete abortion (retained tissue).
(9)Pelvic inflammatory disease.
(10)Missed ectopic pregnancy.
(15)Amniotic fluid embolism.
(17)Placenta previa in subsequent pregnancies.
(18)Pre-term delivery in subsequent pregnancies.
Free access — add to your briefcase to read the full text and ask questions with AI
7. (a) As used in this section, "abortion
complication" means only the following physical or psychological
conditions arising from the induction or performance of an abortion:
(1) Uterine perforation.
(2) Cervical laceration.
(3) Infection.
(4) Vaginal bleeding that qualifies as a Grade 2 or higher adverse
event according to the Common Terminology Criteria for Adverse
Events (CTCAE).
(5) Pulmonary embolism.
(6) Deep vein thrombosis.
(7) Failure to terminate the pregnancy.
(8) Incomplete abortion (retained tissue).
(9) Pelvic inflammatory disease.
(10) Missed ectopic pregnancy.
(11) Cardiac arrest.
(12) Respiratory arrest.
(13) Renal failure.
(14) Shock.
(15) Amniotic fluid embolism.
(16) Coma.
(17) Placenta previa in subsequent pregnancies.
(18) Pre-term delivery in subsequent pregnancies.
(19) Free fluid in the abdomen.
(20) Hemolytic reaction due to the administration of
ABO-incompatible blood or blood products.
(21) Hypoglycemia occurring while the patient is being treated at
the hospital or ambulatory outpatient surgical center.
(22) Allergic reaction to anesthesia or abortion inducing drugs.
(23) Psychological complications, including depression, suicidal
ideation, anxiety, and sleeping disorders.
(24) Death.
(25) Any other adverse event as defined by criteria provided in
the Food and Drug Administration Safety Information and
Adverse Event Reporting Program.
(b) The following persons shall report to the state department each
case in which the person treated a patient suffering from an abortion
complication:
(1) A physician licensed under IC 25-22.5.
(2) A hospital licensed under IC 16-21.
(3) Beginning September 1, 2022, an ambulatory outpatient
surgical center licensed under IC 16-21-2.
(c) The state department shall develop a process for the submission
of a report under this section.
(d) A report under this section shall be submitted to the state
department in the manner prescribed by the state department.
(e) The report under this section must include the following
information concerning the abortion complication:
(1) The date the patient presented for treatment for the abortion
complication.
(2) The age of the patient.
(3) The race of the patient.
(4) The county and state of the patient's residence.
(5) The type of abortion obtained by the patient.
(6) The date of abortion obtained by the patient.
(7) The name of the:
(A) hospital; or
(B) ambulatory outpatient surgical center;
where the patient obtained the abortion.
(8) Whether the patient obtained abortion medication via mail
order or Internet web site, and if so, information identifying the
source of the medication.
(9) Whether the complication was previously managed by the
abortion provider or the abortion provider's required back-up
physician.
(10) The name of the medications taken by the patient as part of
the pharmaceutical abortion regimen, if any.
(11) A list of each diagnosed complication.
(12) A list of each treated complication, with a description of the
treatment provided.
(13) Whether the patient's visit to treat the complications was the
original visit or a follow-up visit.
(14) The date of each follow-up visit, if any.
(15) A list of each complication diagnosed at a follow-up visit, if
any.
(16) A list of each complication treated at a follow-up visit, if any.
(f) On a quarterly basis, the state department shall compile a public
report summarizing the information collected under this section. The
report must include statistics for the previous calendar quarter, with
updated information for the most recent calendar quarter.
(g) The state department shall summarize the aggregate data from
the data submitted under this section and submit the data, on or before
June 30 of each year, to the United States Centers for Disease Control
and Prevention for its inclusion in the annual Vital Statistics Report.
(h) The state department shall ensure that no identifying information
of a pregnant woman is included in the report described in subsection
(f).
(i) This subsection applies after August 31, 2020. Each failure to
report an abortion complication as required under this section is a Class
B misdemeanor.
(j) The state department shall adopt rules under IC 4-22-2 to
implement this section.